Zaloguj Zarejestruj się zadarmo

Affimed N.V organizacji Beta

Jaka jest wartość Beta organizacji Affimed N.V?

Wartość Beta organizacji Affimed N.V. to 1.05

Jaka jest definicja Beta?



BETA wskazuje, czy akcje są bardziej lub mniej zmienne niż rynek jako całość. Beta mniejsza niż 1 wskazuje, że akcje są mniej zmienne niż rynek, a beta więcej niż 1 wskazuje, że akcje są bardziej niestabilne. Zmienność jest mierzona jako fluktuacja ceny wokół średniej.

Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.

Beta firm w Health Care sektor na NASDAQ w porównaniu do Affimed N.V

Czym się zajmuję organizacja Affimed N.V?

affimed (symbol: afmd) is a nasdaq-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. immuno-oncology represents a highly promising approach to cancer treatment that seeks to harness the body’s own immune defenses to attack and destroy tumor cells. natural killer cells, or nk-cells, and t-cells belong to the most potent cells of the human defense arsenal. affimed’s proprietary, next-generation bispecific antibodies, termed tandabs®, are designed to bring nk-cells or t-cells into close proximity to cancer cells that ultimately triggers a signal cascade that leads to the destruction of cancer cells. due to their novel tetravalent tandem architecture, which provides for four binding domains, the tandabs bind to specific targets on immune and cancer cells with high affinity. in addition, tandabs exhibit kinetic properties allowing the administration as regular intravenous infusion and fine-tuning of dosing. affimed beli

Firmy z beta podobne do Affimed N.V